At RegenCen, we use NAD + injections or IV therapy to help jumpstart your metabolism, increase energy, and support more efficient fat burning
In the SURMOUNT-5 trial, participants treated with Zepbound achieved an average weight reduction of 20.2% compared to 13.7% with Wegovy at 72 weeks
Why PlexusDx Compounded Semaglutide Qualifies as an HSA-Eligible Expense PlexusDx sources compounded semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict FDA oversight and state pharmacy board regulations
For athletes, there's another layer to consider
We identified all adults with MASLD and diabetes who were seen in 130 VHA hospitals and associated ambulatory clinics and who initiated either a GLP-1 RA or DPP-4i between January 1, 2006 (GLP-1 RAs and DPP-4is were introduced in the US in 2005 and 2006, respectively), and June 30, 2022